PEPTIDES.BUILDpowered by Astra
Compounded Tirzepatide prescription vial, weight management protocol from Peptides.build
Weight Management

Compounded TirzepatidePrescribed online, from $118/mo

From $118/mo

Weight ManagementInjection

Compounded tirzepatide is a once-weekly injection of tirzepatide, a dual GIP and GLP-1 receptor agonist, prepared by a licensed US 503A pharmacy for one patient. Through Peptides.build a licensed US provider reviews an online intake, prescribes it only if appropriate, and the pharmacy ships it cold-chain, already in solution.

Tirzepatide is the first medication that acts on both the GIP and GLP-1 incretin receptors, which is why it is discussed alongside semaglutide but is not the same drug. It is FDA-approved as the branded products Zepbound and Mounjaro; the compounded medication prescribed here is not those products and is not FDA-approved. A provider reviews your history, decides eligibility and manages the protocol over time.

How much does Compounded Tirzepatide cost?

  • Monthly$250billed monthly
  • 3 months$498≈ $166/mo
  • 6 months$948≈ $158/mo
  • 12 months$1,416≈ $118/moBest value

Compounded Tirzepatide through Peptides.build costs $250 billed monthly, $498 every 3 months, $948 every 6 months, or $1,416 a year (about $118/mo). The price includes the provider review, compounding by a licensed US 503A pharmacy and cold-chain shipping; there is no separate membership fee.

Start Building
Pay over time at checkoutKlarnaAfterpayAffirm
  • All protocols are
  • Made in USA
  • Physician Guided
  • Reviewed by Licensed US provider
  • Fulfilled by 503A US pharmacy
  • Shipping: Cold-chain, all 50 states

Compounded Tirzepatide at a glance

Also known as
tirzepatide, compounded tirz, tirzepatide injection, dual GIP / GLP-1 receptor agonist
Compound
Compounded Tirzepatide
Form
Subcutaneous injection, supplied already reconstituted and labeled with the concentration
Goal
Weight Management. Dual-agonist GLP-1 care, physician guided.
Prescription
Required. Online intake reviewed by a licensed US provider; prescribed only when appropriate.
Pharmacy
Compounded by a licensed US 503A pharmacy, shipped cold-chain to all 50 states (pharmacy and providers).
FDA status
The compounded medication is not FDA-approved; tirzepatide is FDA-approved as the branded drugs Zepbound and Mounjaro.
Price
From $118/mo on the 12-month plan ($250 billed monthly).

Is Compounded Tirzepatide legal? Status under the HHS peptide policy

FDA-approved brand exists. Branded tirzepatide is FDA-approved. Compounded tirzepatide is not FDA-approved and is not part of the HHS peptide policy.

Compounded Tirzepatide price per month · Every protocol's status and price · All prices

How it works

Tirzepatide activates two incretin receptors, GLP-1 and GIP, the signals the gut sends after eating.

Tirzepatide mimics two hormones the gut releases after eating, GIP and GLP-1, which act on appetite signaling, stomach emptying and insulin release. The large randomized trials behind it were run on the branded product in adults with obesity or type 2 diabetes. Your provider sets and adjusts your protocol; dosing is not published on this site.

Who is this considered for?

Dual-agonist GLP-1 care, physician guided.

  • Adults working with a provider on weight management and body composition.
  • People who want physician-guided GLP-1 care with ongoing check-ins.
  • Former athletes rebuilding a sustainable training base.

Who should avoid it?

  • Anyone with a personal or family history of medullary thyroid carcinoma, or with multiple endocrine neoplasia syndrome type 2 (MEN 2).
  • Anyone pregnant, trying to conceive, or breastfeeding.
  • People with a history of pancreatitis, unless their own physician has cleared it.
  • Anyone already taking another GLP-1 medication, or a provider determines is not an appropriate candidate.

Eligibility is always determined by a licensed provider during intake.

What the research says

  • 2022 · Randomized controlled trial

    Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)

    New England Journal of MedicineView citation
  • 2021 · Randomized controlled trial (head to head, type 2 diabetes)

    Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2)

    New England Journal of MedicineView citation
  • 2025 · Randomized controlled trial (head to head, obesity)

    Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5)

    New England Journal of MedicineView citation

Citations retrieved from PubMed. Compounded Tirzepatide is a compounded medication and is not FDA-approved. The research above is provided for education and does not describe outcomes you should expect.

Questions

It contains the same active ingredient, tirzepatide, but it is not the branded product. It is compounded by a licensed 503A pharmacy for one patient from a prescription, carries that pharmacy's label, and is not FDA-approved.

Semaglutide acts on one incretin receptor, GLP-1. Tirzepatide acts on two, GIP and GLP-1. A head-to-head randomized trial of the branded products in adults with obesity has been published; which one fits you is a provider decision.

Not as a compounded medication. Tirzepatide is FDA-approved as the branded drugs Zepbound and Mounjaro. The compounded tirzepatide prescribed here is prepared by a licensed 503A pharmacy for an individual patient; it is not those branded products, and compounded medications are not reviewed or approved by the FDA the way mass-manufactured drugs are.

Yes. You complete an online intake, a licensed US provider reviews it, and Compounded Tirzepatide is prescribed only if it is appropriate for you.

Compounded Tirzepatide is prescribed as a subcutaneous injection. Your provider sets your specific protocol; we do not publish dosing on this page.

Every order is compounded by a licensed US pharmacy and shipped cold-chain to all 50 states.

Some of our protocols combine compounds. Whether a combination is appropriate for you is a decision your provider makes during intake.

Compounded Tirzepatide through Peptides.build costs $250 billed monthly, $498 every 3 months, $948 every 6 months, or $1,416 a year (about $118/mo). The price includes the provider review, compounding by a licensed US 503A pharmacy and cold-chain shipping; there is no separate membership fee.

Complete the online intake for Compounded Tirzepatide (about five minutes), a licensed US provider reviews your history and prescribes it only if it is appropriate for you, a licensed 503A pharmacy compounds it, and it ships cold-chain to your door already reconstituted and labeled with the concentration. You are not charged if the provider decides it is not appropriate.

How to get Compounded Tirzepatide prescribed online

Complete the online intake for Compounded Tirzepatide (about five minutes), a licensed US provider reviews your history and prescribes it only if it is appropriate for you, a licensed 503A pharmacy compounds it, and it ships cold-chain to your door already reconstituted and labeled with the concentration. You are not charged if the provider decides it is not appropriate.

The full process, timing and what is included are on how it works.

Learn more about Compounded Tirzepatide

Often considered alongside Compounded Tirzepatide

Whether any combination fits you is a provider decision made during intake. Related protocols in the catalog:

Compounded Tirzepatide is a compounded medication prepared by a licensed US pharmacy after a prescription from a licensed provider. Compounded medications are not FDA-approved. Nothing here is medical advice.

Build the body that lasts

Build Your Protocol

Protocols on this page are compounded medications and are not FDA-approved. This page is provided for education and is not medical advice. No results are implied or guaranteed. Prescriptions are issued only when a licensed US provider determines treatment is clinically appropriate. Any research referenced describes preclinical or review findings, not expected outcomes.